US Patent Family Members and Approved Drugs for Singapore Patent: 11201700908T
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Singapore Patent: SG11201700908T
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 10,336,983 | 2035-07-31 | bevacizumab | Genentech, Inc. | AVASTIN |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
